Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults. 1991

O M Rutherford, and D A Jones, and J M Round, and C R Buchanan, and M A Preece
Department of Medicine, University College, London, UK.

OBJECTIVE The aim of this study was to determine whether there are any changes in skeletal muscle strength and size and body composition following growth hormone (GH) withdrawal in GH deficient young adults. METHODS A longitudinal, 1-year, open, uncontrolled study of the changes in skeletal muscle and body composition following GH withdrawal was performed. Endocrine status was reassessed at the end of the study period during an insulin tolerance test. Some measurements were repeated after 2 years of treatment. METHODS Twelve (11 male, one female; age range 14-21) patients who had been diagnosed during childhood as growth hormone deficient took part in the study. Four of the 12 patients were found to have a normal GH response on retesting at the end of the study and their results were analysed as a separate group. METHODS Quadriceps and forearm flexor maximum voluntary isometric strength, body fat content and serum IGF-1 were measured at 3-monthly intervals over 1 year. Every 6 months muscle size was measured from computerized tomography scans and fibre area from quadriceps needle biopsy samples. RESULTS For the growth hormone deficient group the 12 month quadriceps strength, size and fibre areas were 94.0% +/- 8.5 (mean +/- SD), 94.5% +/- 6.3 and 85.6% +/- 17.7 respectively of control (baseline) values. Forearm flexor strength and size were 101.4% +/- 7.9 and 92.0% +/- 9.2 of control. Body fat percentage had increased from 19.5% +/- 8.6 to 24.1% +/- 9.5. No change was seen in the non-growth hormone deficient group. CONCLUSIONS Although the changes measured were relatively small they suggest a role for GH in the maintenance of muscle integrity and body composition in the young adult with growth hormone deficiency.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D005260 Female Females
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin

Related Publications

O M Rutherford, and D A Jones, and J M Round, and C R Buchanan, and M A Preece
April 1999, Journal of pediatric endocrinology & metabolism : JPEM,
O M Rutherford, and D A Jones, and J M Round, and C R Buchanan, and M A Preece
January 1996, Obesity research,
O M Rutherford, and D A Jones, and J M Round, and C R Buchanan, and M A Preece
May 1992, The American journal of clinical nutrition,
O M Rutherford, and D A Jones, and J M Round, and C R Buchanan, and M A Preece
September 1999, Diabetes, obesity & metabolism,
O M Rutherford, and D A Jones, and J M Round, and C R Buchanan, and M A Preece
January 1994, Clinical endocrinology,
O M Rutherford, and D A Jones, and J M Round, and C R Buchanan, and M A Preece
March 1994, European journal of endocrinology,
O M Rutherford, and D A Jones, and J M Round, and C R Buchanan, and M A Preece
January 2005, Revista da Associacao Medica Brasileira (1992),
O M Rutherford, and D A Jones, and J M Round, and C R Buchanan, and M A Preece
January 2000, Hormone research,
O M Rutherford, and D A Jones, and J M Round, and C R Buchanan, and M A Preece
April 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement,
O M Rutherford, and D A Jones, and J M Round, and C R Buchanan, and M A Preece
October 1995, European journal of endocrinology,
Copied contents to your clipboard!